As of the latest Form 4 filed Jul 7, 2026.
What Neurogene Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 8 most recent filings for NGNE.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-07 | Cvijic Christine Mikail President and CFO | SSale | −4.20K | $36.13 | $152K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-06 | Cvijic Christine Mikail, President and CFO | SSale | −600.00 | $36.02 | $21.6K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-02 | Cvijic Christine Mikail President and CFO | SSale | −1.53K | $35.23 | $53.9K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-02 | Cvijic Christine Mikail, President and CFO | SSale | −2.53K | $34.58 | $87.5K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Cvijic Christine Mikail, President and CFO | SSale | −739.00 | $34.06 | $25.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Jordan Julie Chief Medical Officer | SSale | −828.00 | $21.89 | $18.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | McMinn Rachel Chief Executive Officer | SSale | −3.35K | $22.07 | $74.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Cvijic Christine Mikail President and CFO | SSale | −2.56K | $21.62 | $55.3K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NGNE’s full analysis or the market-wide insider trading feed. The tabs above jump to NGNE’s other SEC data.
Source: SEC Form 4 filings for NGNE, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.